NATIONAL BANK OF CANADA /FI/ - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,381
-24.1%
1,1360.0%0.00%
Q2 2023$11,036
+74.8%
1,136
+97.2%
0.00%
Q1 2023$6,313
+172.7%
576
+7.5%
0.00%
Q4 2022$2,315
-22.8%
536
+39.9%
0.00%
Q3 2022$3,000
-25.0%
3830.0%0.00%
Q2 2022$4,000
-20.0%
3830.0%0.00%
Q1 2022$5,000
-44.4%
3830.0%0.00%
Q4 2021$9,0003830.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders